NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
